Dr Reddy’’s Announces Collaboration with SkyePharma for New Product utilizing two of SkyePharma’’s pro
Dr Reddys Laboratories Ltd on February 08, 2008 has announced that it has entered into an agreement with SkyePharma PLC (LSE: SKP) to undertake a feasibility study of a product utilizing two of SkyePharmas proprietary drug delivery systems. The costs of this study will be paid by Dr Reddys. SkyePharma will also receive an upfront payment. If the feasibility study is successful, full development activities will begin later this year.